Preferential Induction of EphB4 over EphB2 and Its Implication in Colorectal Cancer Progression
Authors:
- 30 April 2009
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 69 (9) , 3736-3745
Abstract
The receptor tyrosine kinase EphB2 is expressed by colon progenitor cells; however, only 39% of colorectal tumors express EphB2 and expression levels decline with disease progression. Conversely, EphB4 is absent in normal colon but is expressed in all 102 colorectal cancer specimens analyzed, and its expression level correlates with higher tumor stage and grade. Both EphB4 and EphB2 are regulated by the Wnt pathway, the activation of which is critically required for the progression of colorectal cancer. Differential usage of transcriptional coactivator cyclic AMP-responsive element binding protein–binding protein (CBP) over p300 by the Wnt/β-catenin pathway is known to suppress differentiation and increase proliferation. We show that the β-catenin-CBP complex induces EphB4 and represses EphB2, in contrast to the β-catenin-p300 complex. Gain of EphB4 provides survival advantage to tumor cells and resistance to innate tumor necrosis factor-related apoptosis-inducing ligand–mediated cell death. Knockdown of EphB4 inhibits tumor growth and metastases. Our work is the first to show that EphB4 is preferentially induced in colorectal cancer, in contrast to EphB2, whereby tumor cells acquire a survival advantage. [Cancer Res 2009;69(9):3736–45]Keywords
All Related Versions
This publication has 25 references indexed in Scilit:
- Eph-Ephrin Bidirectional Signaling in Physiology and DiseaseCell, 2008
- Eph/ephrin signaling: networksGenes & Development, 2008
- Wnt/β-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotencyProceedings of the National Academy of Sciences, 2007
- EPHB4 and Survival of Colorectal Cancer PatientsCancer Research, 2006
- Receptor Tyrosine Kinase EphB4 Is a Survival Factor in Breast CancerThe American Journal of Pathology, 2006
- Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumoursCarcinogenesis, 2005
- Probing tumor phenotypes using stable and regulated synthetic microRNA precursorsNature Genetics, 2005
- EphB receptors and ephrinB ligands: regulators of vascular assembly and homeostasisCell and tissue research, 2003
- β-Catenin and TCF Mediate Cell Positioning in the Intestinal Epithelium by Controlling the Expression of EphB/EphrinBCell, 2002
- The β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer CellsCell, 2002